ExodusPoint Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,683
| Closed | -$6.14M | – | 1394 |
|
|
2025
Q1 | $6.14M | Buy |
+52,683
| New | +$6.14M | 0.06% | 319 |
|
|
2024
Q4 | – | Sell |
-29,479
| Closed | -$2.65M | – | 1399 |
|
|
2024
Q3 | $2.65M | Buy |
+29,479
| New | +$2.65M | 0.02% | 573 |
|
|
2023
Q2 | – | Sell |
-96,684
| Closed | -$5.96M | – | 1756 |
|
|
2023
Q1 | $5.96M | Buy |
+96,684
| New | +$5.96M | 0.05% | 374 |
|
|
2022
Q4 | – | Sell |
-5,444
| Closed | -$243K | – | 1577 |
|
|
2022
Q3 | $243K | Buy |
+5,444
| New | +$243K | ﹤0.01% | 1547 |
|
|
2022
Q2 | – | Sell |
-11,627
| Closed | -$481K | – | 1874 |
|
|
2022
Q1 | $481K | Buy |
+11,627
| New | +$481K | 0.01% | 1500 |
|
|
2020
Q3 | – | Sell |
-36,804
| Closed | -$3.03M | – | 1677 |
|
|
2020
Q2 | $3.03M | Buy |
+36,804
| New | +$3.03M | 0.08% | 275 |
|
|
2019
Q3 | – | Sell |
-21,703
| Closed | -$559K | – | 1300 |
|
|
2019
Q2 | $559K | Sell |
21,703
-41,069
| -65% | -$1.06M | 0.02% | 392 |
|
|
2019
Q1 | $893K | Buy |
+62,772
| New | +$893K | 0.07% | 201 |
|